We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1126
ORIX
IX
$39.3B
| $2K | ﹤0.01% |
115
| – | – |
2022 Q1
7 quarters
|
|
1127
JBG SMITH
JBGS
$633M
| $2K | ﹤0.01% |
115
| – | – |
2022 Q1
7 quarters
|
|
1128
DELISTED
Nordstrom
JWN
| $2K | ﹤0.01% |
100
| – | – |
2022 Q1
7 quarters
|
|
1129
Lucid Motors
LCID
$1.22B
| $2K | ﹤0.01% |
54
+4
| +8% | +$180 |
2022 Q2
6 quarters
|
|
1130
Leidos
LDOS
$15.8B
| $2K | ﹤0.01% |
22
| – | – |
2022 Q1
7 quarters
|
|
1131
Norwegian Cruise Line
NCLH
$7B
| $2K | ﹤0.01% |
100
| – | – |
2022 Q2
6 quarters
|
|
1132
DELISTED
Paramount Global Class B
PARA
| $2K | ﹤0.01% |
114
| – | – |
2022 Q1
7 quarters
|
|
1133
Invesco WilderHill Clean Energy ETF
PBW
$288M
| $2K | ﹤0.01% |
74
| – | – |
2023 Q1
3 quarters
|
|
1134
PJT Partners
PJT
$3.48B
| $2K | ﹤0.01% |
18
| – | – |
2023 Q2
2 quarters
|
|
1135
SAP
SAP
$261B
| $2K | ﹤0.01% |
14
| – | – |
2022 Q1
7 quarters
|
|
1136
DELISTED
Sealed Air
SEE
| $2K | ﹤0.01% |
45
| – | – |
2022 Q1
7 quarters
|
|
1137
Amplify Junior Silver Miners ETF
SILJ
$3.3B
| $2K | ﹤0.01% |
200
| – | – |
2023 Q3
1 quarter
|
|
1138
Snap
SNAP
$10.6B
| $2K | ﹤0.01% |
103
+3
| +3% | +$37 |
2022 Q1
7 quarters
|
|
1139
Smith & Nephew
SNN
$12.1B
| $2K | ﹤0.01% |
63
| – | – |
2022 Q1
7 quarters
|
|
1140
Acco Brands
ACCO
$417M
| $1K | ﹤0.01% |
188
| – | – |
2022 Q1
7 quarters
|
|
1141
AdvanSix
ASIX
$433M
| $1K | ﹤0.01% |
47
| – | – |
2023 Q2
2 quarters
|
|
1142
Capital Group Dividend Value ETF
CGDV
$38.7B
| $1K | ﹤0.01% |
+41
| New | +$1.13K |
2023 Q4
0 quarters
|
|
1143
Capital Group Growth ETF
CGGR
$25.8B
| $1K | ﹤0.01% |
+43
| New | +$1.11K |
2023 Q4
0 quarters
|
|
1144
WisdomTree US SmallCap Dividend Fund
DES
$2.06B
| $1K | ﹤0.01% |
44
| – | – |
2022 Q1
7 quarters
|
|
1145
Ginkgo Bioworks
DNA
$678M
| $1K | ﹤0.01% |
20
| – | – |
2023 Q1
3 quarters
|
|
1146
Goldman Sachs MarketBeta US Equity ETF
GSUS
$3.42B
| $1K | ﹤0.01% |
+18
| New | +$1.1K |
2023 Q4
0 quarters
|
|
1147
Xtrackers International Real Estate ETF
HAUZ
$1.03B
| $1K | ﹤0.01% |
52
| – | – |
2022 Q3
5 quarters
|
|
1148
JPMorgan Active Value ETF
JAVA
$7.14B
| $1K | ﹤0.01% |
+21
| New | +$1.1K |
2023 Q4
0 quarters
|
|
1149
DELISTED
Leggett & Platt
LEG
| $1K | ﹤0.01% |
25
| – | – |
2022 Q1
7 quarters
|
|
1150
Macy's
M
$6.16B
| $1K | ﹤0.01% |
48
| – | – |
2023 Q1
3 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.